Merck KgaaMKGAF
13F holders, Q1 2026 (March 31)3holders +1
1new positions
0sold out
$124.59avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Merck Kgaa (MKGAF) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($779K), Reik & Co., LLC ($497K) and GAMMA Investing LLC ($4K).
- Company
- Merck Kgaa
- CUSIP
- D5357W103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $779K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 6,236 shares bought, net +6,236 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.04% | New | 6,236 | $779K |
| Reik & Co., LLC | 0.14% | No change | 4,000 | $497K |
| GAMMA Investing LLC | 0.00% | No change | 34 | $4K |
"% of holder's portfolio" is MKGAF's weight in each manager's 13F, not the share of Merck Kgaa the manager owns.